201 related articles for article (PubMed ID: 36831201)
1. Opportunities and Challenges for the Development of MRCK Kinases Inhibitors as Potential Cancer Chemotherapeutics.
Ruscetta VM; Seaton TJ; Shakeel A; Vasconcelos SNS; Viirre RD; Adler MJ; Olson MF
Cells; 2023 Feb; 12(4):. PubMed ID: 36831201
[TBL] [Abstract][Full Text] [Related]
2. A novel small-molecule MRCK inhibitor blocks cancer cell invasion.
Unbekandt M; Croft DR; Crighton D; Mezna M; McArthur D; McConnell P; Schüttelkopf AW; Belshaw S; Pannifer A; Sime M; Bower J; Drysdale M; Olson MF
Cell Commun Signal; 2014 Oct; 12():54. PubMed ID: 25288205
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer.
Unbekandt M; Belshaw S; Bower J; Clarke M; Cordes J; Crighton D; Croft DR; Drysdale MJ; Garnett MJ; Gill K; Gray C; Greenhalgh DA; Hall JAM; Konczal J; Lilla S; McArthur D; McConnell P; McDonald L; McGarry L; McKinnon H; McMenemy C; Mezna M; Morrice NA; Munro J; Naylor G; Rath N; Schüttelkopf AW; Sime M; Olson MF
Cancer Res; 2018 Apr; 78(8):2096-2114. PubMed ID: 29382705
[TBL] [Abstract][Full Text] [Related]
4. Myotonic dystrophy kinase-related Cdc42-binding kinases (MRCK), the ROCK-like effectors of Cdc42 and Rac1.
Zhao Z; Manser E
Small GTPases; 2015; 6(2):81-8. PubMed ID: 26090570
[TBL] [Abstract][Full Text] [Related]
5. Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion.
Wilkinson S; Paterson HF; Marshall CJ
Nat Cell Biol; 2005 Mar; 7(3):255-61. PubMed ID: 15723050
[TBL] [Abstract][Full Text] [Related]
6. Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK.
Wu Q; Ma X; Jin Z; Ni R; Pan Y; Yang G
J Ethnopharmacol; 2023 Oct; 315():116644. PubMed ID: 37196814
[TBL] [Abstract][Full Text] [Related]
7. The actin-myosin regulatory MRCK kinases: regulation, biological functions and associations with human cancer.
Unbekandt M; Olson MF
J Mol Med (Berl); 2014 Mar; 92(3):217-25. PubMed ID: 24553779
[TBL] [Abstract][Full Text] [Related]
8. Co-crystal structures of inhibitors with MRCKβ, a key regulator of tumor cell invasion.
Heikkila T; Wheatley E; Crighton D; Schroder E; Boakes A; Kaye SJ; Mezna M; Pang L; Rushbrooke M; Turnbull A; Olson MF
PLoS One; 2011; 6(9):e24825. PubMed ID: 21949762
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Anticancer Effects of the Analogs of DJ4, a Novel Selective Inhibitor of ROCK and MRCK Kinases.
Kale VP; Hengst JA; Sharma AK; Golla U; Dovat S; Amin SG; Yun JK; Desai DH
Pharmaceuticals (Basel); 2023 Jul; 16(8):. PubMed ID: 37630974
[TBL] [Abstract][Full Text] [Related]
10. A novel selective multikinase inhibitor of ROCK and MRCK effectively blocks cancer cell migration and invasion.
Kale VP; Hengst JA; Desai DH; Dick TE; Choe KN; Colledge AL; Takahashi Y; Sung SS; Amin SG; Yun JK
Cancer Lett; 2014 Nov; 354(2):299-310. PubMed ID: 25172415
[TBL] [Abstract][Full Text] [Related]
11. Adaptor protein LRAP25 mediates myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK) regulation of LIMK1 protein in lamellipodial F-actin dynamics.
Lee ICJ; Leung T; Tan I
J Biol Chem; 2014 Sep; 289(39):26989-27003. PubMed ID: 25107909
[TBL] [Abstract][Full Text] [Related]
12. The CDC42 effector protein MRCKβ autophosphorylates on Threonine 1108.
Unbekandt M; Lilla S; Zanivan S; Olson MF
Small GTPases; 2020 Nov; 11(6):451-460. PubMed ID: 30667325
[TBL] [Abstract][Full Text] [Related]
13. Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a Cdc42 effector in promoting cytoskeletal reorganization.
Leung T; Chen XQ; Tan I; Manser E; Lim L
Mol Cell Biol; 1998 Jan; 18(1):130-40. PubMed ID: 9418861
[TBL] [Abstract][Full Text] [Related]
14. The regulatory roles of ROCK and MRCK kinases in the plasticity of cancer cell migration.
Kale VP; Hengst JA; Desai DH; Amin SG; Yun JK
Cancer Lett; 2015 Jun; 361(2):185-96. PubMed ID: 25796438
[TBL] [Abstract][Full Text] [Related]
15. Myosin II regulation during C. elegans embryonic elongation: LET-502/ROCK, MRCK-1 and PAK-1, three kinases with different roles.
Gally C; Wissler F; Zahreddine H; Quintin S; Landmann F; Labouesse M
Development; 2009 Sep; 136(18):3109-19. PubMed ID: 19675126
[TBL] [Abstract][Full Text] [Related]
16. Rap1 potentiates endothelial cell junctions by spatially controlling myosin II activity and actin organization.
Ando K; Fukuhara S; Moriya T; Obara Y; Nakahata N; Mochizuki N
J Cell Biol; 2013 Sep; 202(6):901-16. PubMed ID: 24019534
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the interaction of phorbol esters with the C1 domain of MRCK (myotonic dystrophy kinase-related Cdc42 binding kinase) alpha/beta.
Choi SH; Czifra G; Kedei N; Lewin NE; Lazar J; Pu Y; Marquez VE; Blumberg PM
J Biol Chem; 2008 Apr; 283(16):10543-9. PubMed ID: 18263588
[TBL] [Abstract][Full Text] [Related]
18. Chelerythrine perturbs lamellar actomyosin filaments by selective inhibition of myotonic dystrophy kinase-related Cdc42-binding kinase.
Tan I; Lai J; Yong J; Li SF; Leung T
FEBS Lett; 2011 May; 585(9):1260-8. PubMed ID: 21457715
[TBL] [Abstract][Full Text] [Related]
19. A Novel Small-Molecule Inhibitor of MRCK Prevents Radiation-Driven Invasion in Glioblastoma.
Birch JL; Strathdee K; Gilmour L; Vallatos A; McDonald L; Kouzeli A; Vasan R; Qaisi AH; Croft DR; Crighton D; Gill K; Gray CH; Konczal J; Mezna M; McArthur D; Schüttelkopf AW; McConnell P; Sime M; Holmes WM; Bower J; McKinnon HJ; Drysdale M; Olson MF; Chalmers AJ
Cancer Res; 2018 Nov; 78(22):6509-6522. PubMed ID: 30279244
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel ROCK inhibitors with anti-migratory and anti-invasive activities.
Patel RA; Liu Y; Wang B; Li R; Sebti SM
Oncogene; 2014 Jan; 33(5):550-5. PubMed ID: 23396364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
